Surveillance of hepatocellular carcinoma (HCC) patients using Protein Induced by Vitamin K (PIVKA-II): A cost-utility analysis for Hong Kong. [PDF]
Yuen MF +5 more
europepmc +1 more source
IGF2BP3-STAT3-METTL3 axis promotes malignant progression in hepatocellular carcinoma (HCC). [PDF]
Xu Y +7 more
europepmc +1 more source
Nanoparticles based on photothermal effects in the treatment of hepatocellular carcinoma (HCC): a meta-analysis and systematic review. [PDF]
Zhang W, Mao X, Lu X, Yu X.
europepmc +1 more source
Hepatocellular carcinoma (HCC): An update on risk factors, surveillance, diagnosis and treatment strategies. [PDF]
Mathew S, Cussens C, Pericleous M.
europepmc +1 more source
Hepatocellular carcinoma in Latin America
Latin America (LA) represents a heterogeneous region in terms of ethnic admixtures and exhibits an intermediate incidence of Hepatocellular carcinoma (HCC).
Lampe, E. +4 more
core
Integrated Global Phosphoproteomic, Bioinformatic, and Machine Learning Analysis Reveals Regulatory Networks of TOP1, TOP2A, TOP2B, and C1orf35 in Hepatocellular Carcinoma (HCC). [PDF]
Mestareehi A.
europepmc +1 more source
Signalling pathways in hepatocellular carcinoma (HCC) metastasis and invasion: Molecular mechanisms and therapeutic implications. [PDF]
Das J +5 more
europepmc +1 more source
A rare but fatal outcome is hepatocellular carcinoma (HCC) progressing to the right atrial tumor thrombus and inferior vena cava. [PDF]
Hoai LT +5 more
europepmc +1 more source

